Home/Filings/4/0001127602-23-023583
4//SEC Filing

Shah Prem S 4

Accession 0001127602-23-023583

CIK 0000064803other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:24 PM ET

Size

19.3 KB

Accession

0001127602-23-023583

Insider Transaction Report

Form 4
Period: 2023-08-31
Shah Prem S
EVP and Group President
Transactions
  • Tax Payment

    Common Stock

    2023-08-31$65.17/sh3,508$228,61650,987.724 total
Holdings
  • Stock Unit (deferred)

    7,870.548
  • Phantom Stock Credits

    Exercise: $1.00Common Stock (12,232.532 underlying)
    12,232.532
  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01Common Stock (2,935 underlying)
    2,935
  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (846 underlying)
    846
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (28,596 underlying)
    28,596
  • Stock Option

    Exercise: $75.24From: 2021-08-31Exp: 2028-08-31Common Stock (26,580 underlying)
    26,580
  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (89,073 underlying)
    89,073
  • Common Stock (Restricted)

    29,649
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (9,469 underlying)
    9,469
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (41,580 underlying)
    41,580
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (28,723 underlying)
    28,723
  • ESOP Common Stock

    4,667.202
Footnotes (12)
  • [F1]Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
  • [F10]Option became exercisable in three equal installments commencing 04/01/2022.
  • [F11]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F12]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
  • [F2]Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
  • [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F5]Option became exercisable in four equal installments commencing 04/01/2017.
  • [F6]Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
  • [F7]Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
  • [F8]Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
  • [F9]Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001900910

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:24 PM ET
Size
19.3 KB